A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture.

We describe in detail a robust, sensitive, and versatile functional assay for G-protein-coupled receptors (GPCRs) expressed in human embryonic kidney (HEK) 293-EBNA (Epstein-Barr virus nuclear antigen) (designated 293E) cells. The ability to grow these cells in suspension, in conjunction with the use of the secreted form of the human placental alkaline phosphatase (SEAP) as the reporter enzyme transcriptionally regulated by 5-cyclic AMP (cAMP) response elements (CREs) (Chen et al., Anal. Biochem. 226, 349-354 (1995)), makes this CRE-SEAP assay potentially attractive for high-throughput screening (HTS). A 293E clonal cell line, stably transfected with the CRE-SEAP plasmid, was initially characterized with compounds known to activate intracellular signal transduction pathways similar to those activated by GPCRs. Forskolin and cAMP analogues were potent at inducing SEAP expression but calcium ionophores (A23187 and ionomycin) were without effect. The forskolin response was also potentiated by the protein kinase C activator phorbol myristate acetate as well as the phosphodiesterase inhibitor isobutylmethylxanthine. Previously established cell lines expressing the G(alphas)-coupled DP or the G(alphaq)-coupled-EP(1) prostanoid receptors were stably transfected with the reporter gene construct and clones were selected based on their ability to secrete SEAP upon agonist challenge. Pharmacological characterization of the DP and EP(1) receptors displayed a similar rank order of potency for several known prostanoids and related compounds to that previously reported using classical binding assays or other functional assays. The CRE-SEAP assay was also used to characterize the EP(1) receptor antagonists SC-51322, SC-51089, and AH6809. In summary, we have established a reporter gene assay for GPCRs that couple to both G(alphas) and G(alphaq) and is amenable to HTS of both agonists and antagonists.

[1]  P E Stanley,et al.  Chemiluminescent and bioluminescent reporter gene assays. , 1994, Analytical biochemistry.

[2]  A. Ford-hutchinson,et al.  Characterization of the recombinant human prostanoid DP receptor and identification of L‐644,698, a novel selective DP agonist , 1998, British journal of pharmacology.

[3]  S. Hill,et al.  Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO‐K1 cells transfected with the human β2‐adrenoceptor , 1998, British journal of pharmacology.

[4]  M. Montminy,et al.  Transcriptional regulation by cyclic AMP. , 1997, Annual review of biochemistry.

[5]  Y. Sugimoto,et al.  Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells. , 1995, Biochimica et biophysica acta.

[6]  P. Lumley,et al.  AH6809, a prostaglandin DP‐receptor blocking drug on human platelets , 1988, British journal of pharmacology.

[7]  R. Stocco,et al.  An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors. , 1999, Analytical biochemistry.

[8]  J. Sánchez-Yagüe,et al.  Inhibition of prostaglandin E2-responsive adenylyl cyclase in embryonal human kidney 293 cells by phorbol esters. , 1995, Journal of lipid mediators and cell signalling.

[9]  E. Borrelli,et al.  Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Nathanson,et al.  Differential regulation of cAMP-mediated gene transcription by m1 and m4 muscarinic acetylcholine receptors. Preferential coupling of m4 receptors to Gi alpha-2. , 1994, The Journal of biological chemistry.

[11]  Johnf . Thompson,et al.  Modulation of firefly luciferase stability and impact on studies of gene regulation. , 1991, Gene.

[12]  L. Fitzgerald,et al.  Measurement of responses from Gi-, Gs-, or Gq-coupled receptors by a multiple response element/cAMP response element-directed reporter assay. , 1999, Analytical biochemistry.

[13]  M. Hagiwara,et al.  Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB , 1992, Cell.

[14]  S. George,et al.  Evaluation of a CRE-Directed Luciferase Reporter Gene Assay as an Alternative to Measuring cAMP Accumulation , 1997 .

[15]  D. Feller,et al.  An efficient cyclic AMP assay for the functional evaluation of beta-adrenergic receptor ligands. , 1999, Journal of receptor and signal transduction research.

[16]  R. Cone,et al.  A colorimetric assay for measuring activation of Gs- and Gq-coupled signaling pathways. , 1995, Analytical biochemistry.

[17]  C. Stratowa,et al.  Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. , 1993, Journal of receptor research.

[18]  G. Milligan.  Signal sorting by G-protein-linked receptors. , 1995, Advances in pharmacology.

[19]  R. Maurer,et al.  Regulation of Activating Transcription Factor-1 and the cAMP Response Element-binding Protein by Ca/Calmodulin-dependent Protein Kinases Type I, II, and IV (*) , 1996, The Journal of Biological Chemistry.

[20]  J. Nicolas,et al.  Engineered cell lines as a tool for monitoring biological activity of hormone analogs. , 1997, Analytical biochemistry.

[21]  J. H. Burn,et al.  ADVANCES IN PHARMACOLOGY , 1957 .

[22]  G. FitzGerald,et al.  Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. , 1993, The Journal of biological chemistry.

[23]  C. Stratowa,et al.  Use of a luciferase reporter system for characterizing G-protein-linked receptors , 1995 .

[24]  J R Feramisco,et al.  Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts , 1994, Molecular and cellular biology.

[25]  M. Montminy,et al.  Structure of the human vasoactive intestinal polypeptide gene. , 1985, DNA.

[26]  T. Krüger,et al.  Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay. , 1999, Molecular pharmacology.

[27]  J. Crider,et al.  Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists , 1999, British journal of pharmacology.

[28]  L. Naylor,et al.  Reporter gene technology: the future looks bright. , 1999, Biochemical pharmacology.

[29]  Y. Boie,et al.  The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. , 2000, Biochimica et biophysica acta.

[30]  T. Gudermann,et al.  Diversity and selectivity of receptor-G protein interaction. , 1996, Annual review of pharmacology and toxicology.

[31]  B. Cullen,et al.  Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. , 1988, Gene.

[32]  J Stables,et al.  Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein coupled receptor signalling. , 1999, Journal of receptor and signal transduction research.

[33]  Y. Boie,et al.  Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.